StockWatch
·

BLISS GVS PHARMA LTD. Q4 FY26 Results

BLISSGVSQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue256.9917.8%29.8%
Total Income268.1513.3%27.7%
Expenditure223.2315.5%19.6%
PBT44.959.9%91.8%
Net Profit37.0049.3%122.2%
OPM17.30%2.51pp6.65pp
NPM13.80%3.33pp5.87pp
EPS3.3753.2%129.3%
View full financials

Informational and educational content only. Not investment advice.